China Resources Pharmaceutical Group Limited (FRA:640)

Market Cap	3.38B -11.2%
Revenue (ttm)	32.83B +4.6%
Net Income	492.20M +20.7%
EPS	0.08 +21.3%
Shares Out	n/a
PE Ratio	6.87
Forward PE	6.24
Dividend	0.02 (2.94%)
Ex-Dividend Date	Jun 17, 2026

Volume	n/a
Open	0.5250
Previous Close	0.5200
Day's Range	0.5250 - 0.5250
52-Week Range	0.4600 - 0.7100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 24, 2026

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular, metabolism, i...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 85,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 640

Financial Performance

In 2025, FRA:640's revenue was 269.57 billion, an increase of 4.62% compared to the previous year's 257.67 billion. Earnings were 4.04 billion, an increase of 21.34%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 28, 2026

Data Sources Report a data error